Article metrics

Download PDFPDF

Multicentre, randomised, open-label, parallel-group study evaluating the efficacy and safety of ixekizumab versus adalimumab in patients with psoriatic arthritis naïve to biological disease-modifying antirheumatic drug: final results by week 52

 

Online download statistics by month:

Online download statistics by month: July 2020 to September 2020

AbstractFullPdf
Jul 202011341128648
Aug 2020794776423
Sep 202018241810478
Total375237141549